New blood thinner tested for critical Heart-Lung machine patients
NCT ID NCT06275555
Summary
This study is comparing two different blood-thinning medications (bivalirudin and heparin) for patients who need a heart-lung machine (ECMO) to stay alive. The goal is to see which drug works better to prevent dangerous blood clots while also causing fewer bleeding problems. Researchers will measure how often clots and serious bleeding happen in 154 adult patients randomly assigned to receive one of the two drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTRACORPOREAL MEMBRANE OXYGENATION COMPLICATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Anzhen Hospital
RECRUITINGBeijing, Beijing Municipality, 100029, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.